dnatrack is a work in progress — updates ship daily. Report a bug or request a feature →

mRNA-based skin identification for forensic applications

International Journal of Legal Medicine, 2011

Study Design

Addressed Question

Identification and specificity of mRNA markers for the identification of skin

Activity Context

None

Category

Recovery

Specifications

RNA Profiling

Variables of Interest

RNA source

Stringency of Control

Reality

Number of Individuals

15

Replicates per Individual and Condition

2-15

Nucleic Acid

RNA

Bodily Origin

menstrual bloodsalivasemenskin (biopsies and swabs)vaginal secretionsvenous blood

Depositor & Contact

Depositor Characteristics

8 men, 7 women, 22-42 years

Criteria for Shedder Status

N/A

Previous Activities

before sampling skin: handwashing, 30 min of not touching often touched surfaces

Contact Scenario

sampling (within 1 hour)

Primary Substrate

Primary Substrate Type

body fluids (skin, blood, saliva, semen, vaginal fluids)

Primary Substrate Material

MucosaSkin

Deposit

regular presence

Delay

N/A

Secondary Substrate

Secondary Substrate Type

N/A

Secondary Substrate Material

N/A

Secondary Substrate Contact

N/A

Further Transfer

N/A

Sampling

Background DNA on Sampled Surface

Sampled

Sampling Time

direct/delayed

Persistence

N/A

Sampling Method

skin, saliva: swabbing; blood: fingerprick, venipuncture; Semen, menstrual blood, vaginal secretions: as described previously

Sampling Area

skin samples: whole hand area

Laboratory Analysis

Extraction

blood: phenol-chloroform + Rneasy Plus mini Kit; saliva: Rneasy Plus Mini kit; skin: Rneasy Fibrous Tissue Mini kit; semen, menstrual blood and vaginal secretion: as described previously

DNA Quantification

RNA: NanoDrop ND-1000 spectrophotometer

Input for Profiling

5-11 µl total RNA for cDNA synthesis, 2µl of 5-fold diluted cDNA for RNA profiling

Profiling

RNA: qPCR of target candidate genes (CALML5, CDSN, DCD, DSC1, FLG, KRT1, KRT21, KRT9, KRT10, LOR, SCGB2A2) and reference genes (ACTB, B2M GAPDH, PP1B, UBC)

Reference Samples

N/A

Profile Interpretation and Mixture Analysis

N/A

RNA Data Interpretation

determination of Ct and dCt (-reference gene)

Results

DNA Quantity

N/A

Profile Quality

N/A

Parameter Used for Comparison

expression levels of mRNAs (Ct) in skin and different forensic body fluids, dCt

Summary of Results

high expression in skin samples together with over-expression in skin samples relative to all other relevant cell types tested determined for: CDSN, LOR, KRT9; most stable reference gene: ACTB; CDSN, LOR and KRT9 expression detected in most skin samples; substantial variation in dCt values between individuals (but not between left and right hand from one individual) - assumed reason: variation in amount of material deposited; dCt samples in skin significantly lower than in non-skin samples for all three markers; slightly increased skin mRNA markers in saliva and vaginal secretions; dCt threshold for skin vs non-skin samples: 2.7 (dCt<2.7 -> skin)

Raised Questions

incorporation of skin-specific mRNA markers into multiplex assays targeting all forensically relevant cell types for mixture determination

Cautionary Remarks

no precise guideline for the detection of skin described: dCt threshold? Detection of one or all skin-specific mRNA markers?; how to implement dCt threshold into mixture analysis?